Urology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 104th Annual Meeting of the American Urological Association

New Approaches to the Management of Male LUTS

Chicago, Illinois / April 25-30, 2009

Chicago - Overactive bladder (OAB) has historically been underrecognized in men as a contributor to lower urinary tract symptoms, with most symptoms being attributed primarily to benign prostatic hyperplasia. A new survey shows the...

PRIORITY PRESS - 104th Annual Meeting of the American Urological Association

The Challenge of Urgency: Recent Advances in Recognizing and Treating Overactive Bladder

Chicago, Illinois / April 25-30, 2009

Chicago - Overactive bladder (OAB) comprises a constellation of lower urinary tract symptoms that include frequency and urgency, with or without urinary incontinence. An estimated 12% to 18% of Canadians have OAB, and that figure may...

PRIORITY PRESS - 24th Annual Congress of the European Association of Urology

Managing Severely Symptomatic Benign Prostatic Hyperplasia: More from CombAT

Stockholm, Sweden / March 17-21, 2009

Stockholm - One consequence of the dramatic growth in the world’s elderly population today is a potentially daunting increase in the number of men who will require treatment for lower urinary tract symptoms associated with benign prostatic...

MEDI-NEWS Based on 2009 ASCO/AUA Guideline

Prostate Cancer Prevention with 5-alpha Reductase Inhibitors: Clinical Guideline and Recommendations

March 2009

For many types of cancer, prevention remains a challenge because of an incomplete understanding of potentially modifiable risk factors. With respect to prostate cancer, an opportunity for chemoprevention arose from the recognition that...

PRIORITY PRESS - 9th Annual Society of Urologic Oncology Winter Meeting

Advances in Androgen-deprivation Therapy for Prostate Cancer

Bethesda, Maryland / December 4-6, 2008

In prostate cancer patients requiring androgen-deprivation therapy (ADT), gonadotropin-releasing hormone (GnRH) antagonists achieve androgen suppression more rapidly and without the testosterone surge and microsurge that accompany...

PRIORITY PRESS - 38th Annual Meeting of the International Continence Society

Issues in Overactive Bladder Therapy: Targeting the Urgency Driver

Cairo, Egypt / October 20-24, 2008

According to Prof. Linda Cardozo, King’s College Hospital, London, UK, urgency including urgency bother is the fundamental symptom of overactive bladder (OAB), driving all other OAB symptoms directly or indirectly. The double-blind...

63rd Annual Meeting of the Canadian Urological Association

Prostate Volume and PSA: Predictors of Disease Progression and Treatment Response in LUTS and BPH

Edmonton, Alberta / June 22-25, 2008

Edmonton - The proportion of men with lower urinary tract symptoms and benign prostatic hyperplasia is substantial and growing. Predicting which men will progress is important as it helps optimize treatment selection. Prostate volume and...

63rd Annual Meeting of the Canadian Urological Association

5-alpha Reductase Inhibitors in Prostate Cancer Prevention: The PCPT Revisited

Edmonton, Alberta / June 22-25, 2008

Edmonton - The PCPT (Prostate Cancer Prevention Trial) was a large independent randomized trial designed to answer whether long-term treatment with the 5-alpha reductase inhibitor (5ARI) finasteride could prevent prostate cancer in men ³55...

103rd Annual Meeting of the American Urological Association

Paradigm Shift in the Primary Prevention of Prostate Cancer: Reanalysis of the PCPT Data

Orlando, Florida / May 17-22, 2008

Orlando - Approximately 200,000 men are diagnosed with prostate cancer in the US annually and over 90% of them receive treatment for it. Reducing the frequency of diagnosed cancer could spare a substantial proportion the consequences of...

103rd Annual Meeting of the American Urological Association

Managing the Three Major Facets of Benign Prostatic Hyperplasia

Orlando, Florida / May 17-22, 2008

Orlando - The MTOPS study demonstrated that combination therapy significantly decreased the four-year incidence of disease progression in men with benign prostatic hyperplasia (BPH) compared with an a-blocker, a 5a-reductase inhibitor...

PAGE 4 OF 8   1 2 3 4 5 6 7 8